Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for Corneal Neovascularization
NCT00555594Phase 3Completed
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Sep 2006
- Primary completion
- Sep 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in corneal neovascularization (CNV), sponsored by Asociación para Evitar la Ceguera en México. Started Sep 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
corneal neovascularization (CNV)
Beyond the preview
Go deeper on NCT00555594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555594.